The potential involvement of Notch signaling in NK cell development

被引:28
作者
Rolink, Antonius G.
Balciunaite, Gina
Demoliere, Corinne
Ceredig, Rhodri
机构
[1] Univ Basel, Dept Clin & Biol Sci, Div Mol Immunol, Ctr Biomed, CH-4058 Basel, Switzerland
[2] Univ Franche Comte, IFR 133, UPRES EA 2284, INSERM U645,Etab Francais Sang Bourgogne Franche, F-25020 Besancon, France
关键词
NK cells; Notch; Delta-like; 1; lymphocyte development;
D O I
10.1016/j.imlet.2006.07.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells constitute an essential element of the innate immune system; however, the cellular and molecular mechanisms that guide their early development are still poorly understood. Here, we demonstrate that in addition to its known crucial role in T cell development, Notch signaling can also be involved in NK cell development. Thus, upon co-culture on OP9 stroma expressing the Notch ligand Delta-like 1 (OP9-DL1), Pax5-deficient pro-B cells, which have multi-lineage potential, efficiently differentiate into T and NK cells. Upon DL-1 signaling, Pax5-deficient pro-B cells down-regulate both surface CD93 expression and transcripts for B cell-specific genes and concomitantly up-regulate T lineage gene transcripts. Subsequent transfer of DL-1-signaled Pax5-deficient pro-B cells onto OP9 stroma in the presence of IL-2 leads to their efficient differentiation into NK1.1(+), functional NK cells. Moreover, bone marrow early progenitor with lymphoid and myeloid differentiation potential (EPLM), which we have previously described as the normal in vivo-equivalent of Pax5-deficient pro-B cells, also gain the ability to differentiate into effector NK cells following transient DL1 Notch-mediated signaling. The potential involvement of Notch signaling in the generation of the NK cell repertoire in vivo is discussed. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 44 条
[1]  
Anderson SK, 2006, CURR TOP MICROBIOL, V298, P59
[2]   INTERACTION OF FC-RECEPTOR (CD16) LIGANDS INDUCES TRANSCRIPTION OF INTERLEUKIN-2 RECEPTOR (CD25) AND LYMPHOKINE GENES AND EXPRESSION OF THEIR PRODUCTS IN HUMAN NATURAL-KILLER CELLS [J].
ANEGON, I ;
CUTURI, MC ;
TRINCHIERI, G ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :452-472
[3]   Interferon gamma production by natural killer (NK) cells and NK1.1(+) T cells upon NKR-P1 cross-linking [J].
Arase, H ;
Arase, N ;
Saito, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2391-2396
[4]   The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential [J].
Balciunaite, G ;
Ceredig, R ;
Rolink, AG .
BLOOD, 2005, 105 (05) :1930-1936
[5]   Frontline:: A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential [J].
Balciunaite, G ;
Ceredig, R ;
Massa, S ;
Rolink, AG .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) :2019-2030
[6]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[7]   Cellular ligands of activating NK receptors [J].
Bottino, C ;
Castriconi, R ;
Moretta, L ;
Moretta, A .
TRENDS IN IMMUNOLOGY, 2005, 26 (04) :221-226
[8]  
BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531
[9]   Natural killer cells, viruses and cancer [J].
Cerwenka, A ;
Lanier, LL .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (01) :41-49
[10]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425